JPWO2020032153A1 - Ｈｓｐａ８遺伝子のプロモーター - Google Patents

Ｈｓｐａ８遺伝子のプロモーター Download PDF

Info

Publication number
JPWO2020032153A1
JPWO2020032153A1 JP2020535864A JP2020535864A JPWO2020032153A1 JP WO2020032153 A1 JPWO2020032153 A1 JP WO2020032153A1 JP 2020535864 A JP2020535864 A JP 2020535864A JP 2020535864 A JP2020535864 A JP 2020535864A JP WO2020032153 A1 JPWO2020032153 A1 JP WO2020032153A1
Authority
JP
Japan
Prior art keywords
nucleotide sequence
promoter
hspa8
seq
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020535864A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020032153A5 (https=
Inventor
兼治 増田
兼治 増田
祐人 中澤
祐人 中澤
渡辺　和彦
和彦 渡辺
真初 西尾
真初 西尾
武 奥村
武 奥村
浩一 野中
浩一 野中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of JPWO2020032153A1 publication Critical patent/JPWO2020032153A1/ja
Publication of JPWO2020032153A5 publication Critical patent/JPWO2020032153A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2020535864A 2018-08-09 2019-08-08 Ｈｓｐａ８遺伝子のプロモーター Pending JPWO2020032153A1 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018149854 2018-08-09
JP2018149854 2018-08-09
PCT/JP2019/031295 WO2020032153A1 (ja) 2018-08-09 2019-08-08 Ｈｓｐａ８遺伝子のプロモーター

Publications (2)

Publication Number Publication Date
JPWO2020032153A1 true JPWO2020032153A1 (ja) 2021-08-12
JPWO2020032153A5 JPWO2020032153A5 (https=) 2022-06-14

Family

ID=69415548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020535864A Pending JPWO2020032153A1 (ja) 2018-08-09 2019-08-08 Ｈｓｐａ８遺伝子のプロモーター

Country Status (10)

Country Link
US (1) US20210317498A1 (https=)
EP (1) EP3835423A4 (https=)
JP (1) JPWO2020032153A1 (https=)
KR (1) KR20210042084A (https=)
CN (1) CN112639098A (https=)
AU (1) AU2019318910A1 (https=)
CA (1) CA3109101A1 (https=)
SG (1) SG11202100996TA (https=)
TW (1) TW202020160A (https=)
WO (1) WO2020032153A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202146432A (zh) * 2020-04-03 2021-12-16 日商第一三共股份有限公司 新基因表現單元
WO2023210607A1 (ja) 2022-04-26 2023-11-02 第一三共株式会社 Ｅｎｏ１遺伝子のプロモーター

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030207832A1 (en) * 1997-11-03 2003-11-06 The Arizona Board Of Regents Inducible expression vectors and methods of use thereof
WO2013080934A1 (ja) * 2011-11-28 2013-06-06 第一三共株式会社 ヒト遺伝子由来プロモーター
CN105018528A (zh) * 2015-08-20 2015-11-04 重庆大学 热休克蛋白基因启动子和四环素基因启动子控制的多基因表达和沉默系统
JP2018038388A (ja) * 2013-08-05 2018-03-15 イマティクス バイオテクノロジーズ ゲーエムベーハー Ｎｓｃｌｃをはじめとする肺がんなどの数種の腫瘍に対する新規免疫療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051411U (ja) 1997-04-25 1998-08-25 信一 朝長 安全プラグ
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
EP3093351B1 (en) * 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
CA2817256A1 (en) * 2010-11-12 2012-05-18 The General Hospital Corporation Polycomb-associated non-coding rnas
SG11201902998SA (en) 2016-10-03 2019-05-30 Daiichi Sankyo Co Ltd PROMOTER OF Hspa5 GENE

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030207832A1 (en) * 1997-11-03 2003-11-06 The Arizona Board Of Regents Inducible expression vectors and methods of use thereof
WO2013080934A1 (ja) * 2011-11-28 2013-06-06 第一三共株式会社 ヒト遺伝子由来プロモーター
JP2018038388A (ja) * 2013-08-05 2018-03-15 イマティクス バイオテクノロジーズ ゲーエムベーハー Ｎｓｃｌｃをはじめとする肺がんなどの数種の腫瘍に対する新規免疫療法
CN105018528A (zh) * 2015-08-20 2015-11-04 重庆大学 热休克蛋白基因启动子和四环素基因启动子控制的多基因表达和沉默系统

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEN, MING-SHUN, ET AL., CELL STRESS AND CHAPERONES, vol. 1, JPN6019038602, 1996, pages 47 - 61, ISSN: 0005203910 *
CHUANG, KUO-HUNG, ET AL., GENE, vol. 405, JPN6019038613, 2007, pages 10 - 18, ISSN: 0005203913 *
LEE, JAE M, ET AL., JOURNAL OF BIOTECHNOLOGY, vol. 133, JPN6019038604, 2008, pages 9 - 17, ISSN: 0005203911 *
RUBENSTEIN, RONALD C., ET AL., AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, vol. 281, JPN6023021481, 2001, pages 43 - 51, ISSN: 0005203909 *
WU, CHIH-LU, ET AL., TRANSGENIC RESEARCH, vol. 20, JPN6019038609, 2011, pages 1217 - 1226, ISSN: 0005203912 *

Also Published As

Publication number Publication date
KR20210042084A (ko) 2021-04-16
EP3835423A4 (en) 2022-08-10
CN112639098A (zh) 2021-04-09
EP3835423A1 (en) 2021-06-16
TW202020160A (zh) 2020-06-01
US20210317498A1 (en) 2021-10-14
WO2020032153A1 (ja) 2020-02-13
CA3109101A1 (en) 2020-02-13
SG11202100996TA (en) 2021-03-30
AU2019318910A1 (en) 2021-02-18

Similar Documents

Publication Publication Date Title
US20230257767A1 (en) Promoter of Hspa5 Gene
CN105950621B (zh) 具有提高外源基因表达活性的dna元件
US9862969B2 (en) Promoter derived from human gene
JPWO2020032153A1 (ja) Ｈｓｐａ８遺伝子のプロモーター
US20250283139A1 (en) PROMOTER OF Eno1 GENE
WO2021201268A1 (ja) 新規遺伝子発現ユニット
HK40122500A (en) Promoter of eno1 gene
HK40043731A (en) Promotor for hspa8 gene
HK40004749A (en) Promoter of hspa5 gene

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220603

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230529

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231127